• Multiple Myeloma 

 My work at Loyola University incorporates both pre-clinical and clinical research as well as direct patient care. I am passionate about working with patients to find the best treatment choice tailored to each individual. My focus is primarily on plasma cell disorders including monoclonal gammopathy of unknown significance (MGUS), smoldering myeloma, multiple myeloma, plasma cell leukemia, amyloidosis (both systemic and ATTR), light chain deposition disease, and POEMS disease. However, I see patients for all malignant hematology conditions including acute and chronic leukemia, non-hodgkin and hodgkins lymphoma, a well as MDS and aplastic anemia. In particular, I focus on the role of high dose chemotherapy and autologous or allogeneic transplant as well as cellular therapy (CAR-T) in the care of patients. Further, it is my goal that every patient be offered and ideally treated on a clinical trial in order to improve patient outcomes. I am involved in translational as well as early and late phase clinical trial development.